Literature DB >> 4739112

Psychiatric aspects of normal pressure hydrocephalus.

E Rice, S Gendelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4739112

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  [Clinical observations on communicating hydrocephalus of unknown eitology (author's transl)].

Authors:  H Rau; A Fäs; W Horst; G Baumgartner
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

2.  Normal-pressure hydrocephalus and psychiatric disorders.

Authors: 
Journal:  Br Med J       Date:  1973-05-05

3.  Acquired hydrocephalus. I. A clinical analysis of 160 patients studied for hydrocephalus.

Authors:  F Jensen; F T Jensen
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

4.  Surgical indications in normotensive hydrocephalus. A retrospective analysis of the relations of some diagnostic findings to the results of surgical treatment.

Authors:  G Belloni; C di Rocco; C Focacci; G Galli; G Maira; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

5.  Disturbances of cerebrospinal fluid (CSF) circulation--neuropsychiatric symptoms and neuroradiological contribution.

Authors:  E Hofmann; T Becker; J Meixensberger; M Jackel; M Schneider; H Reichmann
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Indications for the surgical treatment of hydrocephalic dementia.

Authors:  C Vivenza; R Bricolo; L Princi; M Baldini; G D Ore
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

Review 7.  Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia.

Authors:  Jack R Foucher; David Luck
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

8.  Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial.

Authors:  Romy Scholz; Johannes Lemcke; Ullrich Meier; Dirk Stengel
Journal:  Trials       Date:  2018-10-17       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.